Skip to main content
Clinical Trials/CTRI/2025/09/095136
CTRI/2025/09/095136Not yet recruitingPhase 2/3

A clinical study of sushrutokta manjisthadi tail on vrana ropan

Sgmpg ayurvedic medical college and hospital1 site in 1 country50 target enrollmentStarted: October 3, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Rate of wound healing.

Study Overview

Brief Summary

The present clinical trial study is designed to assess the evaluate the efficacy of Manjisthdi Tail in the managment of Vrana w.s.r to vrana ropan. In ayurveda Susruta has described Manjisthadi formulations as possessing ropan, sodhana and vrana ropan properties so this research aims to provide scientific validation of a classical Ayurvedic formulation in wound managment.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
15.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • On the basis of sign & symptoms seen of “Vrana”.
  • The age group of patient taken between 15-60 years.

Exclusion Criteria

  • Patient associated with chronic disease like AIDS, Cancer, Hepatitis B, T.B, Cardiac Complications, Diabetic, Pregnant or Lactating women etc.

Outcomes

Primary Outcomes

Rate of wound healing.

Time Frame: Baseline (Day 0), Day 7, Day 14, Day 21, and Day 28 (or until complete healing, whichever is earlier).

Time taken for complete epithelialization(Vrna Ropan).

Time Frame: Baseline (Day 0), Day 7, Day 14, Day 21, and Day 28 (or until complete healing, whichever is earlier).

Secondary Outcomes

  • 1.Pain reduction.(2. Reduction in local inflammation (erythema, edema, tenderness).)

Investigators

Sponsor
Sgmpg ayurvedic medical college and hospital
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Raju Kumar

S.G.M.P.G. Ayurvedic Medical College and Hospital, Saheri, Ghazipur, UP-233302

Study Sites (1)

Loading locations...

Similar Trials